{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:43:26Z","timestamp":1774554206870,"version":"3.50.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T00:00:00Z","timestamp":1444262400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12348-015-0060-1","type":"journal-article","created":{"date-parts":[[2015,10,8]],"date-time":"2015-10-08T08:24:09Z","timestamp":1444292649000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Combined systemic and ocular chemotherapy for anterior segment metastasis of systemic mantle cell lymphoma"],"prefix":"10.1186","volume":"5","author":[{"given":"Aniruddha","family":"Agarwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Ali","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Rhoades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren S.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Hanout","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip J.","family":"Bierman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William W.","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan Dong","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,8]]},"reference":[{"issue":"1","key":"60_CR1","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.critrevonc.2011.05.001","volume":"82","author":"S Cortelazzo","year":"2012","unstructured":"Cortelazzo S, Ponzoni M, Ferreri AJ, Dreyling M (2012) Mantle cell lymphoma. Crit Rev Oncol Hematol 82(1):78\u2013101. doi: 10.1016\/j.critrevonc.2011.05.001","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"60_CR2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1182\/blood-2014-05-521898","volume":"125","author":"E Campo","year":"2015","unstructured":"Campo E, Rule S (2015) Mantle cell lymphoma: evolving management strategies. Blood 125(1):48\u201355. doi: 10.1182\/blood-2014-05-521898","journal-title":"Blood"},{"issue":"12","key":"60_CR3","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/ajh.23615","volume":"88","author":"JM Vose","year":"2013","unstructured":"Vose JM (2013) Mantle cell lymphoma: 2013 update on diagnosis, risk-stratification, and clinical management. Am J Hematol 88(12):1082\u20131088. doi: 10.1002\/ajh.23615","journal-title":"Am J Hematol"},{"issue":"8","key":"60_CR4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bjo.2008.146910","volume":"93","author":"P Rasmussen","year":"2009","unstructured":"Rasmussen P, Sjo LD, Prause JU, Ralfkiaer E, Heegaard S (2009) Mantle cell lymphoma in the orbital and adnexal region. Br J Ophthalmol 93(8):1047\u20131051. doi: 10.1136\/bjo.2008.146910","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"60_CR5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1442-9071.2012.02811.x","volume":"41","author":"A Mashayekhi","year":"2013","unstructured":"Mashayekhi A, Shields CL, Shields JA (2013) Iris involvement by lymphoma: a review of 13 cases. Clin Experiment Ophthalmol 41(1):19\u201326. doi: 10.1111\/j.1442-9071.2012.02811.x","journal-title":"Clin Experiment Ophthalmol"},{"issue":"3","key":"60_CR6","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1600-0420.2006.00845.x","volume":"85","author":"MA Economou","year":"2007","unstructured":"Economou MA, Kopp ED, All-Ericsson C, Seregard S (2007) Mantle cell lymphoma of the iris. Acta Ophthalmol Scand 85(3):341\u2013343. doi: 10.1111\/j.1600-0420.2006.00845.x","journal-title":"Acta Ophthalmol Scand"},{"issue":"4 Suppl 1","key":"60_CR7","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/OPX.0000000000000218","volume":"91","author":"JP Reid","year":"2014","unstructured":"Reid JP, Puglis CL, Slagle WS (2014) Intraocular mantle cell lymphoma of the iris. Optom Vis Sci 91(4 Suppl 1):S25\u201329. doi: 10.1097\/opx.0000000000000218","journal-title":"Optom Vis Sci"},{"issue":"7","key":"60_CR8","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1200\/JCO.2007.14.2620","volume":"26","author":"AV Chappelow","year":"2008","unstructured":"Chappelow AV, Singh AD, Perez VL, Lichtin A, Pohlman B, Macklis R (2008) Bilateral panocular involvement with mantle-cell lymphoma. J Clin Oncol 26(7):1167. doi: 10.1200\/jco.2007.14.2620","journal-title":"J Clin Oncol"},{"issue":"3","key":"60_CR9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/030089160909500321","volume":"95","author":"P Franco","year":"2009","unstructured":"Franco P, Filippi AR, Ricca I, Raucci C, Ricardi U (2009) Eyelid localization in mantle cell lymphoma: long-lasting complete remission after surface brachytherapy. Tumori 95(3):385\u2013388","journal-title":"Tumori"},{"issue":"1","key":"60_CR10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/bjophthalmol-2013-304043","volume":"98","author":"KL Larkin","year":"2014","unstructured":"Larkin KL, Saboo US, Comer GM, Forooghian F, Mackensen F, Merrill P, Sen HN, Singh A, Essex RW, Lake S, Lim LL, Vasconcelos-Santos DV, Foster CS, Wilson DJ, Smith JR (2014) Use of intravitreal rituximab for treatment of vitreoretinal lymphoma. Br J Ophthalmol 98(1):99\u2013103. doi: 10.1136\/bjophthalmol-2013-304043","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"60_CR11","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/bjo.2007.127928","volume":"92","author":"S Frenkel","year":"2008","unstructured":"Frenkel S, Hendler K, Siegal T, Shalom E, Pe'er J (2008) Intravitreal methotrexate for treating vitreoretinal lymphoma: 10\u00a0years of experience. Br J Ophthalmol 92(3):383\u2013388. doi: 10.1136\/bjo.2007.127928","journal-title":"Br J Ophthalmol"},{"issue":"21","key":"60_CR12","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1158\/1078-0432.CCR-14-0010","volume":"20","author":"AF Herrera","year":"2014","unstructured":"Herrera AF, Jacobsen ED (2014) Ibrutinib for the treatment of mantle cell lymphoma. Clin Cancer Res 20(21):5365\u20135371. doi: 10.1158\/1078-0432.ccr-14-0010","journal-title":"Clin Cancer Res"},{"issue":"2","key":"60_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00277-006-0193-2","volume":"86","author":"DS Ritchie","year":"2007","unstructured":"Ritchie DS, Seymour JF, Grigg AP, Roberts AW, Hoyt R, Thompson S, Szer J, Prince HM (2007) The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma. Ann Hematol 86(2):101\u2013105. doi: 10.1007\/s00277-006-0193-2","journal-title":"Ann Hematol"},{"key":"60_CR14","doi-asserted-by":"crossref","unstructured":"Martin N, Borchiellini D, Coso D, Gastaud L, Boscagli A, Saudes L, Re D, Gutnecht J, Garnier G, Petit E, Barriere J, Naman H, Rossignol B, Thyss A, Peyrade F (2015) High-dose chemotherapy with full BEAM followed by autologous stem cell transplantation is an effective treatment for elderly patients with poor-prognosis lymphoma. Leukemia & lymphoma:1\u201326. doi: 10.3109\/10428194.2014.1001987","DOI":"10.3109\/10428194.2014.1001987"},{"issue":"9873","key":"60_CR15","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","volume":"381","author":"MJ Rummel","year":"2013","unstructured":"Rummel MJ, Niederle N, Maschmeyer G, Banat GA, von Grunhagen U, Losem C, Kofahl-Krause D, Heil G, Welslau M, Balser C, Kaiser U, Weidmann E, Durk H, Ballo H, Stauch M, Roller F, Barth J, Hoelzer D, Hinke A, Brugger W (2013) Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial. Lancet 381(9873):1203\u20131210. doi: 10.1016\/s0140-6736(12)61763-2","journal-title":"Lancet"},{"issue":"7","key":"60_CR16","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.3109\/10428194.2010.486093","volume":"51","author":"ES Ahn","year":"2010","unstructured":"Ahn ES, Singh AD, Smith SD (2010) Mantle cell lymphoma with uveal metastasis. Leuk Lymphoma 51(7):1354\u20131355. doi: 10.3109\/10428194.2010.486093","journal-title":"Leuk Lymphoma"},{"issue":"Pt 2","key":"60_CR17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/eye.2000.63","volume":"14","author":"SA Rowley","year":"2000","unstructured":"Rowley SA, Fahy GT, Brown LJ (2000) Mantle cell lymphoma presenting as a choroidal mass: part of the spectrum of uveal lymphoid infiltration. Eye (Lond) 14(Pt 2):241\u2013244. doi: 10.1038\/eye.2000.63","journal-title":"Eye (Lond)"},{"issue":"4","key":"60_CR18","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ajo.2013.05.025","volume":"156","author":"H Krema","year":"2013","unstructured":"Krema H, Santiago RA, Gonzalez JE, Pavlin CJ (2013) Spectral-domain optical coherence tomography versus ultrasound biomicroscopy for imaging of nonpigmented iris tumors. Am J Ophthalmol 156(4):806\u2013812. doi: 10.1016\/j.ajo.2013.05.025","journal-title":"Am J Ophthalmol"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-015-0060-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12348-015-0060-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-015-0060-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T05:33:56Z","timestamp":1567229636000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.joii-journal.com\/content\/5\/1\/30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,8]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1186\/s12348-015-0060-1","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,8]]},"article-number":"30"}}